负载扁蒴藤素的纳米颗粒下调MTDH/AEG-1抑制范可尼贫血蛋白并增加对铂类化疗的敏感性
该研究探讨MTDH作为RNA结合蛋白调控范可尼贫血(FA)通路组分FANCD2和FANCI,从而影响铂类耐药。负载扁蒴藤素的纳米颗粒可显著降低癌细胞中MTDH、FANCD2和FANCI水平,恢复铂类敏感性;在子宫内膜癌患者来源异种移植模型中,扁蒴藤素纳米制剂联合顺铂明显抑制肿瘤生长。
要点
- MTDH通过RNA结合蛋白作用调控FANCD2和FANCI表达。
- 扁蒴藤素显著降低癌细胞MTDH、FANCD2和FANCI水平。
- 扁蒴藤素纳米制剂联合顺铂明显抑制子宫内膜癌PDX肿瘤生长。
核心结论
- MTDH参与FANCD2和FANCI的转录后调控。
- 扁蒴藤素可通过抑制FA通路增加MTDH过表达肿瘤对铂类药物的敏感性。
研究设计与样本
- 采用RNA结合蛋白免疫沉淀法检测FANCD2和FANCI mRNA与MTDH的结合。
- 采用纳米沉淀法制备负载扁蒴藤素的纳米颗粒。
- 在携带患者来源异种移植瘤的免疫缺陷小鼠中,分别给予负载扁蒴藤素的纳米颗粒、顺铂及两者联合治疗。
主要发现
- MTDH作为RNA结合蛋白调控FANCD2和FANCI的表达,二者在铂类引起的链间交联损伤中起关键作用。
- 扁蒴藤素显著降低癌细胞中MTDH、FANCD2和FANCI水平,从而恢复对铂类化疗的敏感性。
- 在子宫内膜癌患者来源异种移植模型中,扁蒴藤素纳米制剂联合顺铂明显抑制肿瘤生长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Platinum compounds have been widely used as a primary treatment for many types of cancer. However, resistance is the major cause of therapeutic failure for patients with metastatic or recurrent disease, thus highlighting the need to identify novel factors driving resistance to Platinum compounds. Metadherin (MTDH, also known as AEG-1 and LYRIC), located in a frequently amplified region of chromosome 8, has been consistently associated with resistance to chemotherapeutic agents, though the precise mechanisms remain incompletely defined. METHODS: The mRNA of FANCD2 and FANCI was pulled down by RNA-binding protein immunoprecipitation. Pristimerin-loaded nanoparticles were prepared using the nanoprecipitation method. Immunocompromised mice bearing patient-derived xenograft tumors were treated with pristimerin-loaded nanoparticles, cisplatin and a combination of the two. RESULTS: MTDH, through its recently discovered role as an RNA binding protein, regulates expression of FANCD2 and FANCI, two components of the Fanconi anemia complementation group (FA) that play critical roles in interstrand crosslink damage induced by platinum compounds. Pristimerin, a quinonemethide triterpenoid extract from members of the Celastraceae family used to treat inflammation in traditional Chinese medicine, significantly decreased MTDH, FANCD2 and FANCI levels in cancer cells, thereby restoring sensitivity to platinum-based chemotherapy. Using a patient-derived xenograft model of endometrial cancer, we discovered that treatment with pristimerin in a novel nanoparticle formulation markedly inhibited tumor growth when combined with cisplatin. CONCLUSIONS: MTDH is involved in post-transcriptional regulation of FANCD2 and FANCI. Pristimerin can increase sensitivity to platinum-based agents in tumors with MTDH overexpression by inhibiting the FA pathway.
引用
- Bi J, Areecheewakul S, Li Y, et al. MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy. Gynecol Oncol. 2019. PMID: 31477281. doi:10.1016/j.ygyno.2019.08.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。